Form 4 for MRLN Merlin, Inc.
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0001213900-26-030909 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-18 | 2026-03-16 | MRLN | George Matthew Spencer | CEO, Dir | A - Grant | — | +14.89M | 14.89M | New | — |
| D | 2026-03-18 | 2026-03-16 | MRLN | George Matthew Spencer | CEO, Dir | A - Grant | — | +1.51M | 1.51M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | A | A | 14,890,622 | — | 14,890,622 | D | — | — | (F1) Represents securities received as part of the Issuer's business combination, in connection with the Business Combination Agreement, dated as of August 13, 2025, by and among the Issuer (formerly known as Inflection Point Acquisition Corp. IV), IPDX Merger Sub, Inc., a direct wholly owned subsidiary of the Issuer, and Merlin Labs, Inc. ("Legacy Merlin"), pursuant to which the common stock of Legacy Merlin automatically converted into newly issued shares of Common Stock. In addition, each Legacy Merlin stock option was automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. |
| 2 | Derivative | Stock Option | 2026-03-16 | A | A | 1,512,485 | — | 1,512,485 | D | $8.48 · — to 2036-02-03 | 1,512,485 Common Stock | (F1) Represents securities received as part of the Issuer's business combination, in connection with the Business Combination Agreement, dated as of August 13, 2025, by and among the Issuer (formerly known as Inflection Point Acquisition Corp. IV), IPDX Merger Sub, Inc., a direct wholly owned subsidiary of the Issuer, and Merlin Labs, Inc. ("Legacy Merlin"), pursuant to which the common stock of Legacy Merlin automatically converted into newly issued shares of Common Stock. In addition, each Legacy Merlin stock option was automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. (F2) The stock option will vest in full on February 4, 2027. |